Earnings Call
Aug 4, 2026
Q2 FY2026
EPS Estimate
1.68
EPS Actual
1.54
Post-Earnings Close
$162.47
Earnings Reaction
+2.3%
Emerson's fiscal second quarter 2026 was defined by two countervailing forces: a geopolitical disruption in the Middle East that clipped roughly a point off underlying sales growth, and an underlying demand environment that remained genuinely healthy across North America, India, and the company's five secular growth verticals. Underlying orders grew 5%, backlog rose 9% year-over-year to $8.2 billion, and book-to-bill held at 1.07, metrics that give management credible visibility into a stronger second half. Adjusted EPS of $1.54 came in near the top of guidance and grew 4% year-over-year despite the conflict headwind and a roughly $0.09 drag from a software contract renewal dynamic that will fade as the year progresses.
Report generated on Aug 3, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full EMR analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.